Production (Stage)
Aurinia Pharmaceuticals Inc.
AUPH
$7.99
-$0.16-1.96%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 317.17% | 105.32% | 206.72% | 106.28% | 58.98% |
| Total Depreciation and Amortization | 0.19% | -1.76% | -7.01% | 573.57% | 576.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.36% | -92.01% | 11.64% | -22.84% | -127.36% |
| Change in Net Operating Assets | -132.06% | 15.69% | 13.32% | 172.82% | 18.81% |
| Cash from Operations | 106.99% | 110.41% | 228.26% | 660.62% | 41.28% |
| Capital Expenditure | -41.67% | 6.02% | -- | -- | 96.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -36.95% | 763.04% | 46.62% | -611.14% | 95.36% |
| Cash from Investing | -36.97% | 726.87% | 46.34% | -588.69% | 98.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.25% | 53.69% | 15.05% | -- | -- |
| Issuance of Common Stock | 68.14% | 144.13% | -79.48% | -4.91% | 237.03% |
| Repurchase of Common Stock | -213.84% | -1,125.89% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -227.80% | -313.23% | -16.72% | -825.70% | -1,018.30% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -209.12% | 1,768.08% | 110.58% | -325.72% | 401.37% |